Opportunity Information: Apply for PAR 18 425

The NIDA Program Project Grant Applications (P01, Clinical Trial Optional) opportunity (FOA number PAR-18-425) is a National Institutes of Health discretionary grant designed to fund large, coordinated research programs in areas that are high priority for the National Institute on Drug Abuse (NIDA). The core purpose is to support collaborative, multidisciplinary teams whose combined work produces clear scientific synergy, meaning the overall program achieves stronger, more impactful results than the same studies would if they were funded as separate, stand-alone research grants. In practice, this mechanism is meant for institutions and investigators who can organize multiple complementary research efforts around a shared set of addiction-related questions and demonstrate that the projects actively strengthen one another through shared concepts, methods, resources, data, or coordinated aims.

A defining feature of this program project mechanism is its required structure. Each funded program must include at least three highly meritorious research projects that operate together under one overarching program theme that directly advances NIDA's mission and goals. The expectation is not simply that three projects fall under a broad topic, but that they are intentionally integrated so that the combined approach offers substantial advantages, such as accelerating discovery, enabling cross-validation across studies, harmonizing measures for shared datasets, building shared infrastructure, or linking basic, translational, and clinical perspectives in a coordinated way. The "clinical trial optional" label indicates that applicants may propose clinical trials if appropriate to their scientific aims, but a clinical trial is not required for eligibility under this announcement.

The funding instrument is a grant under the P01 activity code, and the activity category listed for the opportunity is Education and Health under CFDA number 93.279. While the summary information provided does not specify an award ceiling or the expected number of awards, P01s are generally substantial, multi-project awards where review criteria heavily emphasize the added value of the program structure, the strength of each individual project, and the evidence that the projects together create outcomes that could not be achieved as efficiently or convincingly through separate awards.

Eligibility is broad and includes many types of U.S.-based applicant organizations. Eligible applicants include state, county, city or township, and special district governments; independent school districts; public and state-controlled institutions of higher education; private institutions of higher education; federally recognized tribal governments; tribal organizations other than federally recognized tribal governments; public housing authorities and Indian housing authorities; nonprofits with or without 501(c)(3) status (other than institutions of higher education); for-profit organizations other than small businesses; small businesses; and other eligible entities. The FOA also explicitly highlights additional eligible applicant categories such as Alaska Native and Native Hawaiian Serving Institutions, Asian American Native American Pacific Islander Serving Institutions (AANAPISIs), Hispanic-serving Institutions, Historically Black Colleges and Universities (HBCUs), Tribally Controlled Colleges and Universities (TCCUs), faith-based or community-based organizations, eligible federal agencies, regional organizations, tribal governments that are not federally recognized, and U.S. territories or possessions.

Foreign eligibility is more limited and follows NIH policy distinctions. Non-domestic (non-U.S.) entities (foreign organizations and foreign institutions) are not eligible to apply as the applicant organization. However, non-domestic components of U.S. organizations are eligible to be included, and foreign components, as defined in the NIH Grants Policy Statement, are allowed. In other words, the applicant must be a domestic eligible organization, but the program can include certain foreign components when they are justified and consistent with NIH rules.

The source data indicates the opportunity was created on 2017-11-29 and lists an original closing date of 2019-08-16. Even if those dates are historical, the key takeaway for understanding the announcement is the scientific and organizational intent: NIDA is looking for integrated, multi-project programs where at least three projects jointly tackle critical addiction-related problems with clear coordination and measurable synergy, using a team science model that delivers more than the sum of its parts.

  • The National Institutes of Health in the education, health sector is offering a public funding opportunity titled "NIDA Program Project Grant Applications (P01, Clinical Trial Optional)" and is now available to receive applicants.
  • Interested and eligible applicants and submit their applications by referencing the CFDA number(s): 93.279.
  • This funding opportunity was created on 2017-11-29.
  • Applicants must submit their applications by 2019-08-16. (Agency may still review applications by suitable applicants for the remaining/unused allocated funding in 2026.)
  • Eligible applicants include: State governments, County governments, City or township governments, Special district governments, Independent school districts, Public and State controlled institutions of higher education, Native American tribal governments (Federally recognized), Public housing authorities/Indian housing authorities, Native American tribal organizations (other than Federally recognized tribal governments), Nonprofits having a 501 (c) (3) status with the IRS, other than institutions of higher education, Nonprofits that do not have a 501 (c) (3) status with the IRS, other than institutions of higher education, Private institutions of higher education, For-profit organizations other than small businesses, Small businesses, Others.
Apply for PAR 18 425

[Watch] Creating a grant proposal using the step-by-step wizard inside the applicant portal:

FAQs: NIDA Program Project Grant Applications (P01, Clinical Trial Optional) - PAR-18-425

What is this grant opportunity?

This opportunity is the NIDA Program Project Grant Applications (P01, Clinical Trial Optional) funding announcement (FOA number PAR-18-425). It is a National Institutes of Health (NIH) discretionary grant designed to support large, coordinated research programs in areas that are high priority for the National Institute on Drug Abuse (NIDA).

What is the main purpose of the P01 Program Project mechanism?

The core purpose is to fund collaborative, multidisciplinary research teams whose combined work creates clear scientific synergy. That means the overall program is expected to produce stronger, more impactful results than the same studies would if they were funded as separate, stand-alone research grants.

What does "scientific synergy" mean in the context of this opportunity?

Scientific synergy means the integrated program achieves outcomes that are greater than the sum of its parts. NIDA expects applicants to show that the projects actively strengthen one another through shared concepts, methods, resources, data, or coordinated aims, leading to results that could not be achieved as efficiently or convincingly through separate awards.

How many research projects are required in a P01 application under this announcement?

Each funded program must include at least three highly meritorious research projects that operate together under one overarching program theme aligned with NIDA's mission and goals.

Is it enough for the projects to be in the same broad topic area?

No. The expectation is not simply that three projects fall under a broad topic. The projects must be intentionally integrated so the combined approach offers substantial advantages over separate projects, such as coordinated aims, shared resources, harmonized measures for shared datasets, or cross-study validation.

What kinds of integration or coordination does NIDA expect to see?

The announcement emphasizes integration that creates program-level advantages, which can include accelerating discovery, enabling cross-validation across studies, harmonizing measures for shared datasets, building shared infrastructure, or linking basic, translational, and clinical perspectives in a coordinated way.

What does "Clinical Trial Optional" mean?

"Clinical Trial Optional" means applicants may propose clinical trials if a trial is appropriate to the scientific aims, but a clinical trial is not required for eligibility under this announcement.

What is the funding instrument and activity code?

The funding instrument is a grant, and the activity code is P01 (Program Project).

What is the CFDA number and listed activity category?

The opportunity is listed under CFDA 93.279, and the activity category is Education and Health.

Does the provided information specify a maximum award amount or the expected number of awards?

No. The summary information provided does not specify an award ceiling or the expected number of awards.

What general level of support is typical for P01 awards?

While this summary does not provide specific dollar limits, it characterizes P01s as generally substantial, multi-project awards where review places heavy emphasis on the added value of the integrated program structure and the strength of each individual project.

Who is eligible to apply as the applicant organization?

Eligibility is broad and includes many types of U.S.-based applicant organizations, including various levels of government (state, county, city or township, special district), independent school districts, public and state-controlled institutions of higher education, private institutions of higher education, federally recognized tribal governments, certain tribal organizations, public housing authorities and Indian housing authorities, nonprofits (with or without 501(c)(3) status, other than institutions of higher education), for-profit organizations other than small businesses, small businesses, and other eligible entities.

Are minority-serving institutions and specific community-based groups included in eligibility?

Yes. The FOA explicitly highlights additional eligible categories such as Alaska Native and Native Hawaiian Serving Institutions, AANAPISIs, Hispanic-serving Institutions, HBCUs, TCCUs, faith-based or community-based organizations, eligible federal agencies, regional organizations, tribal governments that are not federally recognized, and U.S. territories or possessions.

Can a non-U.S. (foreign) organization apply as the main applicant?

No. Non-domestic (non-U.S.) entities (foreign organizations and foreign institutions) are not eligible to apply as the applicant organization.

Can the program include foreign components if the applicant is a U.S. organization?

Yes. Non-domestic components of U.S. organizations are eligible to be included, and foreign components (as defined in the NIH Grants Policy Statement) are allowed. In practical terms, the applicant must be a domestic eligible organization, but the program may include certain foreign components when justified and consistent with NIH rules.

What is the role of the overarching program theme?

The program theme is the unifying scientific focus that ties the required three (or more) research projects together. The theme must directly advance NIDA's mission and goals and provide the rationale for why the projects belong in one coordinated program rather than separate awards.

What is NIDA looking for at a high level?

NIDA is looking for integrated, multi-project programs where at least three projects jointly tackle critical addiction-related problems with clear coordination and measurable synergy, using a team science model that delivers more than the sum of its parts.

When was this opportunity created, and what closing date is listed in the source data?

The source data indicates the opportunity was created on 2017-11-29 and lists an original closing date of 2019-08-16.

Do the listed dates guarantee the opportunity is currently open?

No. The information provided describes those dates as source data and notes they may be historical. Based on the details given here alone, the safe interpretation is that the dates are part of the record, but they do not confirm current availability.

What is the most important structural requirement emphasized in this announcement?

The defining structural requirement highlighted here is that the program must include at least three highly meritorious research projects that are intentionally integrated under a single overarching theme, with clear evidence that the multi-project structure creates meaningful scientific advantages.

Browse more opportunities from the same agency: National Institutes of Health

Browse more opportunities from the same category: Education, Health

Next opportunity: Science, Technology, Innovation, and Partnerships in Higher Education Program

Previous opportunity: Innovations in Mechanisms and Interventions to Address Mental Health in HIV Prevention and Care Continuum (R01 Clinical Trial Optional)

Applicant Portal:

Are you interested in learning about about how to apply for this government funding opportunity? You can create a free applicant account and receive instant access to our applicant portal that many business owners like you have benefited from.

Apply for PAR 18 425

 

Applicants also applied for:

Applicants who have applied for this opportunity (PAR 18 425) also looked into and applied for these:

Funding Opportunity
Building Evidence: Effective Palliative/End of Life Care Interventions (R01 Clinical Trial Optional) Apply for PAR 18 173

Funding Number: PAR 18 173
Agency: National Institutes of Health
Category: Education, Health
Funding Amount: Case Dependent
Image-guided Drug Delivery (R01 Clinical Trial Optional) Apply for PAR 18 252

Funding Number: PAR 18 252
Agency: National Institutes of Health
Category: Education, Health
Funding Amount: Case Dependent
Exploratory/Developmental Surgical Disparities Research (R21 Clinical Trial Optional) Apply for PAR 18 289

Funding Number: PAR 18 289
Agency: National Institutes of Health
Category: Education, Health
Funding Amount: $200,000
NIDA Research Center of Excellence Grant Program (P50 Clinical Trial Optional) Apply for PAR 18 224

Funding Number: PAR 18 224
Agency: National Institutes of Health
Category: Education, Health
Funding Amount: Case Dependent
NIDA Core "Center of Excellence" Grant Program (P30 Clinical Trial Optional) Apply for PAR 18 225

Funding Number: PAR 18 225
Agency: National Institutes of Health
Category: Education, Health
Funding Amount: Case Dependent
Paul Calabresi Career Development Award for Clinical Oncology (K12 Clinical Trial Optional) Apply for PAR 18 292

Funding Number: PAR 18 292
Agency: National Institutes of Health
Category: Education, Health
Funding Amount: Case Dependent
Multi-Site Pilot and Feasibility Studies for System-Level Implementation of Substance Use Prevention and Treatment Services (R34 Clinical Trial Optional) Apply for PAR 18 223

Funding Number: PAR 18 223
Agency: National Institutes of Health
Category: Education, Health
Funding Amount: $225,000
Improving Smoking Cessation in Socioeconomically Disadvantaged Populations via Scalable Interventions (R21 Clinical Trial Optional) Apply for PAR 18 250

Funding Number: PAR 18 250
Agency: National Institutes of Health
Category: Education, Health
Funding Amount: $200,000
Improving Smoking Cessation in Socioeconomically Disadvantaged Populations via Scalable Interventions (R01 Clinical Trial Optional) Apply for PAR 18 251

Funding Number: PAR 18 251
Agency: National Institutes of Health
Category: Education, Health
Funding Amount: Case Dependent
Multi-Site Studies for System-Level Implementation of Substance Use Prevention and Treatment Services (R01 Clinical Trial Optional) Apply for PAR 18 222

Funding Number: PAR 18 222
Agency: National Institutes of Health
Category: Education, Health
Funding Amount: $500,000
Avenir Award Program for Genetics or Epigenetics of Substance Use Disorders (DP1 Clinical Trial Optional) Apply for PAR 18 226

Funding Number: PAR 18 226
Agency: National Institutes of Health
Category: Education, Health
Funding Amount: $300,000
Obesity and Asthma: Awareness and Self- Management (R01 Clinical Trial Optional) Apply for PA 18 379

Funding Number: PA 18 379
Agency: National Institutes of Health
Category: Education, Health
Funding Amount: Case Dependent
Cancer Research Education Grants Program - Curriculum or Methods Development (R25) Apply for PAR 18 476

Funding Number: PAR 18 476
Agency: National Institutes of Health
Category: Education, Health
Funding Amount: $150,000
Cancer Research Education Grants Program - Research Experiences (R25) Apply for PAR 18 478

Funding Number: PAR 18 478
Agency: National Institutes of Health
Category: Education, Health
Funding Amount: $300,000
Cancer Research Education Grants Program - Courses for Skills Development (R25) Apply for PAR 18 477

Funding Number: PAR 18 477
Agency: National Institutes of Health
Category: Education, Health
Funding Amount: $300,000
NIDA Avant-Garde Award Program for HIV/AIDS and Drug Use Research (DP1, Clinical Trial Optional) Apply for RFA DA 18 019

Funding Number: RFA DA 18 019
Agency: National Institutes of Health
Category: Education, Health
Funding Amount: $500,000
The NCI Transition Career Development Award (K22 - Independent Clinical Trial Not Allowed) Apply for PAR 18 467

Funding Number: PAR 18 467
Agency: National Institutes of Health
Category: Education, Health
Funding Amount: Case Dependent
The NCI Transition Career Development Award (K22 Independent Clinical Trial Required) Apply for PAR 18 466

Funding Number: PAR 18 466
Agency: National Institutes of Health
Category: Education, Health
Funding Amount: Case Dependent
Using Information Technology to Support Systematic Screening and Treatment of Depression in Cancer (R21 Clinical Trial Optional) Apply for PA 18 492

Funding Number: PA 18 492
Agency: National Institutes of Health
Category: Education, Health
Funding Amount: $200,000
Using Information Technology to Support Systematic Screening and Treatment of Depression in Cancer (R01 Clinical Trial Optional) Apply for PA 18 493

Funding Number: PA 18 493
Agency: National Institutes of Health
Category: Education, Health
Funding Amount: Case Dependent

 

Grant application guides and resources

It is always free to apply for government grants. However the process may be very complex depending on the funding opportunity you are applying for. Let us help you!

Apply for Grants

 

Inside Our Applicants Portal

  • Grants Repository - Access current and historic funding opportunities with ease. Thousands of funding opportunities are published every week. We can help you sort through the database and find the eligible ones to apply for.
  • Applicant Video Guides - The grant application process can be challenging to follow. We can help you with intuitive video guides to speed up the process and eliminate errors in submissions.
  • Grant Proposal Wizard - We have developed a network of private funding organizations and investors across the United States. We can reach out and submit your proposal to these contacts to maximize your chances of getting the funding you need.
Access Applicants Portal

 

Premium leads for funding administrators, grant writers, and loan issuers

Thousands of people visit our website for their funding needs every day. When a user creates a grant proposal and files for submission, we pass the information on to funding administrators, grant writers, and government loan issuers.

If you manage government grant programs, provide grant writing services, or issue personal or government loans, we can help you reach your audience.

Learn More

 

 

Request more information:

Would you like to learn more about this funding opportunity, similar opportunities to "PAR 18 425", eligibility, application service, and/or application tips? Submit an inquiry below:

Don't forget to subscribe to our grant alerts mailing list to receive weekly alerts on new and updated grant funding opportunities like this one in your email.

 

Ask a Question: